Serum Institute of India (SII) chief Adar Poonawalla has said that the ‘Covishield’ vaccine that has been approved by the Indian drug regulator for restricted emergency use will be available at Rs 1,000 per shot in the retail market, if the government gives a nod for its private sale. Poonawalla said SII is selling the shots to the government for Rs 200 for the first 10 crore shots and then there will be tendering.
So, the vaccine that also requires a booster dose will cost people around Rs 2,000 in the private retail market. Notably, the company has a ready stock of 50 million doses.
SII to double output
The SII chief added, “We are expecting all formalities to be completed in the next 7 to 10 days and a very quick rollout after that and we’re hoping to reach 70-80 million doses of actual supply in the next one month, or maybe a month-and-a-half at the most.” The company is hopeful of doubling its monthly output by March.
Meanwhile, the government has imposed an embargo on SII exporting vaccine to other countries or selling it in the private market.
Over 1.03 cr COVID-19 cases
The health ministry on Monday informed that 16,504 fresh cases of COVID-19 have been reported in India in the past 24 hours. The addition of the fresh cases has taken the COVID-19 case tally past 1.03 crore. Also, 214 COVID-19 related deaths were reported by the ministry during this period. The addition of the fresh fatalities has taken India’s death toll due to the deadly virus to 1,49,649.
Of the over 1.03 crore coronavirus cases reported so far, over 2.43 lakh are active cases of the virus. It is above 2 per cent of the total caseload. Interestingly, 99.46 lakh cases have recovered from the viral infection so far.
To read the latest news in Gujarati click here